For Healthcare Professionals

Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

clipboard-pencil

About the study

This is a prospective, serum proteomics study of men who are to undergo prostate biopsy. The purpose is to determine if proteomic profiles can be used to distinguish between men with prostate cancer on biopsy from men with no cancer on biopsy.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:


  1. Men aged 18 years or older
  2. Have a PSA level between 2 and 10 ng/ml
  3. May or may not have an abnormal digital rectal examination
  4. Scheduled for trans-rectal ultrasound (TRUS) guided systematic prostate biopsy as part of routine medical care. All sites (Department of Urology at SUNY Downstate Medical Center, Brooklyn, the Department of Urology, New York Presbyterian Hospital, Weill Medical College of Cornell University, Manhattan and the Department of Urology, Kings County Hospital) will perform a standardized 14 core biopsy protocol.
  5. Signed, informed consent
  6. Patient must be able to attend the pre-biopsy blood draw

EXCLUSION CRITERIA

Exclusion Criteria:


  1. Any period of prior/current treatment with hormonal therapy (LHRH agonist/antagonist,antiandrogen, 5-alpha-reductase inhibitor)
  2. Prior pelvic radiation
  3. A period of less than 6 months prior/current treatment with an alpha-blocker
  4. Previous diagnosis of prostate cancer

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Prostate Cancer,Elevated Prostate Specific Antigen (PSA)

Age (in years)

18+

Phase

Not Applicable

Participants needed

500

Est. Completion Date

Oct 31, 2024

Treatment type

Interventional


Sponsor

Memorial Sloan Kettering Cancer Center

ClinicalTrials.gov identifier

NCT00773773

Study number

08-114

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.